參考文獻(xiàn)/References:
[1] 王勝云,陳德昌.降鈣素原和C-反應(yīng)蛋白與膿毒癥患者病情嚴(yán)重程度評分的相關(guān)性研究及其對預(yù)后的評估價(jià)值[J]. 中華危重病急救醫(yī)學(xué),2015,27(2): 97-101.
[2] Strle K, Zhou J H, Shen W H, et al.Interleukin-10 in the brain.[J]. Critical Reviews in Immunology,2001,21(5): 427.
[3] 韓靖,杜玉明,袁聰俐,等,大鼠盲腸結(jié)扎與穿刺膿毒癥模型的建立與分析[J].上海交通大學(xué)學(xué)報(bào),2017,35(4):1-6.
[4] Gao Y L,Lu B,Zhai J H,et al.The parenteral vitamin C improves sepsis and sepsis-induced multiple organ dysfunction syndrome via preventing cellular Immunosuppression[J]. Mediators Inflamm,2017,2017:1-12.
[5] Kakihana Y,Ito T,Nakahara M, et al.Sepsis-induced myocardial dysfunction: pathophysiology and management[J]. Journal of Intensive Care,2016,4(1): 22.
[6] Ooboshi H, Ibayashi S, Shichita T, et al.Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia[J]. Circulation,2005,111(7): 913-919.
[7] Kim M Y, Lim Y Y, Kim H M, et al.Synergistic inhibition of tumor necrosis factor-alpha-stimulated pro-inflammatory cytokine expression in HaCaT cells by a combination of rapamycin and mycophenolic acid[J]. Ann Dermatol,2015, 27(1): 32-39.
[8] Lewis D H, Chan D L, Pinheiro D, et al.The immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cells[J]. J Vet Intern Med,2012, 26(3): 457-482.
[9] 劉楠,陳榮華,鄭安,等.IL-10對大鼠腦缺血損傷保護(hù)作用的研究[J]. 中國藥學(xué)雜志,2005, 39(13): 988-990.
相似文獻(xiàn)/References:
[1]黃郴,徐馴宇.胸腔鏡外科領(lǐng)域新進(jìn)展[J].福建醫(yī)藥雜志,2017,39(4):1.
[2]鄭飛,李建成.長鏈非編碼RNA MALAT1對肺癌細(xì)胞放療敏感性的作用[J].福建醫(yī)藥雜志,2021,43(06):125.
ZHENG Fei,LI Jiancheng.Effect of long non-coding RNA MALAT1 on radiosensitivity of lung cancer cells[J].FUJIAN MEDICAL JOURNAL,2021,43(06):125.
[3]陳新旺,薛聃,黃崢慧,等.慢性阻塞性肺疾病對肺癌患者免疫治療相關(guān)性肺炎風(fēng)險(xiǎn)影響的Meta分析[J].福建醫(yī)藥雜志,2022,44(06):25.
CHEN Xinwang,XUE Dan,HUANG Zhenghui,et al.Impact of chronic obstructive pulmonary disease on risk of immune checkpoint inhibitor pneumonitis in patients with lung cancer: a meta-analysis[J].FUJIAN MEDICAL JOURNAL,2022,44(06):25.